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Human H3N2 influenza A viruses were known to preferentially bind to sialic acid (SA) in a2,6Gal linkage on red blood cells
(RBC). However, H3N2 viruses isolated in MDCK cells after 1992 did not agglutinate chicken RBC (CRBC). Experiments with
point-mutated hemagglutinin (HA) of A/Aichi/51/92, one of these viruses, revealed that an amino acid change from Glu to Asp
at position 190 (E190D) was responsible for the loss of ability to bind to CRBC. A/Aichi/51/92 did not agglutinate CRBC
treated with a2,3-sialidase, suggesting that SAa2,3Gal on CRBC might not inhibit the binding of the virus to SAa2,6Gal on
CRBC. However, the virus agglutinated derivatized CRBC resialylated with SAa2,6Galb1,4GlcNAc. These findings suggested
that the E190D change might have rendered the HA able to distinguish sialyloligosaccharides on the derivatized CRBC
containing the SAa2,6Galb1,4GlcNAc sequence from those on the native CRBC. © 2000 Academic Press
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The receptor-binding specificity of a virus is significant
in determining the range of hosts which a virus can infect
or the degree of tissue tropism which a virus can display.
Terminal sialic acids of sialylglycoproteins and ganglio-
sides are known to be receptor determinants for influ-
enza viruses (Gottschalk, 1959). Influenza virus infection
is initiated by interactions between viral glycoprotein,
hemagglutinin (HA), and sialic acid moieties of glycocon-
jugates on host cells (reviewed in Wiley and Skehel,
1987). The interaction between sialic acids on target
cells and HA is occasionally influenced by sialic acids on
HA. Ohuchi et al. (1995) indicated that sialic acids on
oligosaccharides close to the receptor-binding site of HA
interfered with the binding of HA to erythrocytes. On the
other hand, the receptor binding of influenza viruses is
occasionally dependent on the manner in which a sialic
acid is linked to the penultimate galactose, that is,
whether the sialic acid is in a2,3Gal linkage (SAa2,3Gal)
or a2,6Gal linkage (SAa2,6Gal). The preferential binding
f the viruses to erythrocytes derivatized with sialyltrans-
erase was used to estimate the binding specificity to
Aa2,3Gal or SAa2,6Gal (Rogers and Paulson, 1983;
ogers et al., 1983; Connor et al., 1994).
Human influenza A viruses (H3N2) isolated in MDCK
cells after 1992 are no longer able to agglutinate chicken
1 To whom correspondence and reprint requests should be ad-
ressed at Nagoya City University, Department of Virology, Medical
chool, Nagoya City 467-8601, Japan. Fax: 181-52-853-3638. E-mail:
obusawa@med.nagoya-cu.ac.jp.
587red blood cells (CRBC) (Ch2 viruses), but do agglutinate
human RBC (HRBC), as is shown in this study. We pre-
viously reported two phenotypes of H1N1 human influ-
enza A viruses isolated after 1991, one of which aggluti-
nated CRBC, whereas the other did not (Morishita et al.,
1993). Both viruses were in cocirculation in the 1991/1992
and 1995/1996 seasons, and neither was predominant
(Morishita et al., 1997). After the cells infected with the
latter group of H1N1 viruses were treated with a bacte-
rial sialidase, these cells acquired the ability to hemad-
sorb chicken erythrocytes, suggesting that interference
by sialic acids on HA was one reason why hemaggluti-
nation of CRBC was not observed (Tong et al., 1998). In
contrast to H1N1, the Ch2 type of H3N2 viruses has
become the major form of circulating H3N2 since the
1992/1993 season. This altered receptor-binding ability
has been retained for 8 years among the predominant
H3N2 viruses in circulation. In this study, to elucidate the
mechanism by which Ch2 viruses underwent this alter-
ation in receptor-binding ability, we examined the recep-
tor binding of site-specific mutated HAs of Ch2 virus and
characterized sialic acids on both native and derivatized
RBC.
RESULTS
Characterization of Ch2 viruses
Human influenza A viruses isolated in MDCK cells
after 1992 in Japan could not agglutinate CRBC. The
hemagglutination titers of the following viruses were
examined: Ch2 viruses, A/Aichi/51/92 (51/92), A/Aichi/
48/93 (48/93), A/Aichi/18/95 (18/95), A/Aichi/46/96 (46/
0042-6822/00 $35.00
Copyright © 2000 by Academic Press
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588 NOBUSAWA ET AL.96), A/Aichi/30/97 (30/97), A/Aichi/11/98 (11/98), and
A/Aichi/3/99 (3/99), all of which are representatives of
consecutive influenza seasons from 1992 to 1999, and
two other viruses, A/Aichi/2/68 (AI/68) and A/Chiang Mai/
156/88 (CM/88), both of which agglutinate CRBC (Ch1
viruses) and were used for reference. All of the Ch2
viruses agglutinated HRBC at hemagglutination titers of
64 to 128, but did not agglutinate CRBC. In contrast, Ch1
viruses agglutinated both kinds of erythrocytes at hem-
agglutination titers of 128.
Three independent clones of each Ch2 virus were
obtained by plaque purification in MDCK cells and used
to confirm that the hemagglutination phenotype of Ch2
viruses was predominant in the respective virus isolates.
Hemagglutination titers of the respective cloned viruses
did not show hemagglutination ability toward CRBC but
did show hemagglutination ability to HRBC (as well as
did their parent viruses), suggesting that the loss of
CRBC hemagglutination was common but not a particu-
lar characteristic of a Ch2 virus population.
To examine whether the quantity of HA relative to
amounts of other viral proteins on the virion was lower in
Ch2 virus than in Ch1 virus, proteins of the purified
iruses were analyzed by sodium dodecyl sulfate–poly-
crylamide gel electrophoresis. The ratios of the quantity
f nucleoprotein to HA and M1 proteins of 51/92 or of
0/97 (Ch2 viruses) were almost equal to those of
M/88 (Ch1 virus). This suggested that the lack of hem-
gglutination of CRBC using Ch2 viruses could not be
scribed to a lower level of viral HA protein on the virion.
Hemadsorption of cells infected with Ch2 and Ch1
iruses was further compared. Figure 1 shows the he-
adsorption of MDCK (Fig. 1a) and Cos (Fig. 1b) cells
nfected with 51/92 (Figs. 1a and 1b, panels A, panels B,
nd panels C), one of the Ch2 viruses, as well as of
hose infected with CM/88 (Figs. 1a and 1b, panels D and
anels E) (Ch1 virus). When both kinds of cells were
nfected with 51/92, both adsorbed HRBC efficiently
Figs. 1a and 1b, panels A), but hemadsorption was
ndetectable with CRBC (Figs. 1a and 1b, panels B). On
he other hand, cells infected with CM/88 adsorbed both
inds of erythrocytes (Figs. 1a and 1b, panels D and
anels E). These results suggested that the feature of
emadsorption of Cos cells infected with 51/92 and
M/88 was equivalent to that of MDCK cells infected
ith the respective viruses. On the other hand, to avoid
he interference by sialic acids on HA with hemadsorp-
ion, the cells infected with 51/92 were treated with Vibrio
holerae neuraminidase (VCNA). However, the VCNA
reatment did not improve the hemadsorption of both
ypes of the cells with CRBC (Figs. 1a and 1b, panels C).
he hemadsorption phenotype of the other Ch2 viruses
xamined was similar to that of 51/92. These results
uggested that the loss of binding ability of Ch2 viruses
o CRBC was neither a host-cell-specific characteristic
f
wor the result of interference by sialic acids on the HA
lycoconjugates.
haracterization of expressed HA proteins in Cos
ells
To examine the molecular mechanism of the lack of
emagglutination ability of Ch2 viruses with CRBC, we
ompared the intrinsic receptor-binding ability of the HA
f Ch2 and Ch1 viruses in the absence of the possible
nfluence of other viral proteins. For this purpose, the HA
f 51/92 (51-HA) and of CM/88 (CM-HA) were expressed
n Cos cells using an expression vector, pME18S, as
escribed under Materials and Methods. Cell-surface
xpression of expressed HA was confirmed by cell-sur-
FIG. 1. Hemadsorption ability of cells [(a) MDCK, (b) Cos] infected
with 51/92 (panels A, panels B, and panels C) and CM/88 (panels D and
panels E). At 18 h postinfection, the cells were washed with medium
and hemadsorption was tested with HRBC (panels A and panels D) and
CRBC (panels B, panels C, and panels E). Prior to the hemadsorption
assay, cells (C) were treated with VCNA (1 unit/ml) at 37°C for 1 h. Cells
were observed under a phase-contrast microscope at 2003 magnifi-
cation.ace immunofluorescence. Expressed 51-HA and CM-HA
ere detected on the cell surface at similar levels (Table
5e text.
589A RECEPTOR DETERMINANT FOR RECENT HUMAN H3N2 VIRUSES1). The receptor-binding capacity of each respective HA
was estimated from its ability to hemadsorb the two
types of RBC. Quantification of hemadsorption was per-
formed by means of a hemolysis assay (Table 1). Both
HA types exhibited hemadsorption toward HRBC to an
equal extent, although CM-HA could also adsorb CRBC
while 51-HA could not (Table 1). VCNA treatment of the
cells expressing 51-HA did not improve the hemadsorp-
tion with CRBC. These results indicated that 51-HA had
undergone an intrinsic loss in its ability to bind to CRBC.
Determination of the portion responsible for the
inability of 51-HA to hemadsorb CRBC
To determine the region within 51-HA that was respon-
sible for the loss of binding ability to CRBC, we con-
structed three chimeras of 51-HA and CM-HA and ex-
pressed them on Cos cells as described under Materials
and Methods (Fig. 2). Chimera 1 consisted of 219 resi-
dues (1 to 219) of 51-HA and 348 residues (220 to 567) of
CM-HA, chimera 2 consisted of 186 residues (1 to 186) of
51-HA and 381 residues (187 to 567) of CM-HA, and
chimera 3 contained 36 residues (186 to 219) of CM-HA
in the corresponding region of 51-HA. All chimeric HAs
were detected on the cell surface at levels equal to those
of 51-HA and CM-HA (Table 1). Chimeras 1 and 3 exhib-
ited efficient hemadsorption with CRBC and HRBC as did
CM-HA, but chimera 2 was able to adsorb only HRBC
T
Amino Acid Sequence, Cell Surface Expres
Amino acid residue at positiona
189 190 193
1-HA S D S
CM-HA R E N
Chimera 1 R E N
Chimera 2 S D S
Chimera 3 R E N
51-mut 1 S D S
51-mut 2 R E N
51-mut 3 R E S
51-mut 4 S E S
51-mut 5 R D S
CM-mut 1 R E N
CM-mut 2 S D S
CM-mut 3 S D N
CM-mut 4 R D N
CM-mut 5 S E N
a Bold letters indicate amino acid substitutions.
b Determined by flow cytometry. Averages of three experiments.
c Absorbance of released hemoglobin at 540 nm as described in th(Table 1). This result allowed us to narrow our search to
the region between amino acid residues at positions 186and 219. Subsequent sequence analysis showed that
51-HA and CM-HA are different by four amino acids in
this region and these residues are at positions, 189, 190,
193, and 198.
To determine the amino acid residue(s) responsible for
the inability of 51-HA-infected cells to hemadsorb CRBC,
we constructed 10 mutants of 51-HA (51-mut1 to mut5)
and CM-HA (CM-mut1 to mut5) (Table 1) by site-specific
mutagenesis and expressed them on Cos cells as de-
scribed under Materials and Methods. Intracellular
transport of all mutant HAs to the cell surface was ana-
lyzed by cell-surface immunofluorescence. Expressed
d Hemadsorption Ability of Expressed HA
Percentage of
positive cellsb
Hemadsorptionc
98 HRBC CRBC
E 66.2 0.473 0.006
A 72.0 0.458 0.134
A 70.9 0.426 0.145
E 77.1 0.155 0.007
A 67.5 0.276 0.135
A 64.8 0.506 0.009
E 62.8 0.448 0.117
E 60.5 0.592 0.119
E 58.6 0.548 0.110
E 52.0 0.524 0.005
E 60.6 0.466 0.131
A 50.9 0.210 0.003
A 66.5 0.161 0.005
A 63.8 0.166 0.010
A 59.0 0.429 0.070
Averages of experiments in triplicate are shown.
FIG. 2. HA chimeras between 51-HA and CM-HA. The nucleotide
sequences of 51-HA cDNA were replaced with sequences of the
corresponding region of CM-HA cDNA using shared restriction enzyme
sites to generate three chimeric HAs (Chimeras 1–3). The amino acidABLE 1
sion, an
1numbering system used was in accordance with that used for A/Aichi/
2/68 (Wilson et al., 1981).
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590 NOBUSAWA ET AL.HAs were observed on the surface of cells at almost
equal levels (Table 1). Hemadsorption ability was ana-
lyzed by means of a hemolysis assay (Table 1). 51-HA
and all of its mutants exhibited almost the same levels of
hemadsorption with HRBC. 51-mut2, -mut3, and -mut4
acquired an ability to hemadsorb CRBC at a level similar
to that of CM-HA, while 51-mut1 and -mut5 did not.
51-mut2, -mut3, and -mut4 shared an amino acid substi-
tution at position 190 from Asp to Glu. In contrast, CM-
mut2, -mut3, and -mut4, all of which have an amino acid
change at position 190 from Glu to Asp, appeared inca-
pable of CRBC hemadsorption. Hemadsorption of HRBC
with these mutants was half that of CM-HA. CM-mut1
and -mut5 showed nearly the same hemadsorption abil-
ity as that of CM-HA, although hemadsorption of CRBC
with CM-mut5 was slightly decreased. These results
indicated that Asp, instead of Glu, at position 190 had an
inhibitory effect on the binding ability of 51-HA and
CM-HA to CRBC, suggesting that the lack of detection of
CRBC hemagglutination using 51/92 could be ascribed to
Asp 190. Furthermore, Asp 190 of CM-mut2, -mut3, and
-mut4 slightly abrogated the binding ability of these mu-
tant HAs to HRBC, even though that of 51-HA did not.
Since the amino acid residues surrounding the receptor-
binding sites of CM-HA are not necessarily the same as
those of 51-HA, Asp 190 may conceivably have a slightly
different effect on the receptor-binding ability of the re-
spective HAs.
Characterization of sialic acids on RBC
To compare HRBC and CRBC in terms of the species
and amounts of sialic acid on their surfaces, we em-
ployed a method using sialidase and high-performance
liquid chromatography (HPLC), as described under Ma-
terials and Methods. With this approach, sialic acid res-
idues of oligosaccharides on the cell surface of these
erythrocytes were released and analyzed by HPLC. The
sialic acids released from CRBC and HRBC by bacterial
sialidase from Vibrio cholerae and Arthrobacter were all
-acetylneuraminic acids (NeuAc), and N-glycolylneura-
inic acids were not detected. The amount of NeuAc on
BC was calculated from the height of the peak for the
euAc standard. The average total sialic acid content
as 617 and 325 nmol/ml for packed HRBC and CRBC,
espectively (Table 2). On the other hand, the average
mount of NeuAc in a2,3 linkage cleaved by a2,3-siali-
ase of Salmonella typhimurium LT2 and Newcastle dis-
ase virus was 177 and 182 nmol/ml for packed HRBC
nd CRBC, respectively (Table 2). These results indi-
ated that the ratio of NeuAc in a2,3 linkage to that of
total NeuAc was higher in CRBC (56%) than in HRBC
(28%). Using linkage-specific lectins and fluorescence-
activated cell sorting, Ito et al. (1997a) compared ratios of
sialic acids in a2,3 linkage to those in a2,6 linkage in
oth types of erythrocytes and showed that the ratio was
Clightly higher in CRBC than in HRBC. In this study, we
id not directly examine the amount of sialic acid in a2,6
inkage since a2,6-sialidase was not available. However,
ccording to the results of Ito et al. (1997a), most of the
ialic acids, other than those in a2,3 linkage, might be in
a2,6 linkage.
Hemagglutination with derivatized RBC
Gambaryan et al. (1997) previously reported that H3N2
uman influenza viruses isolated in MDCK cells exhibited
igh affinity for sialic acids in a2,6 linkage. To clarify
hether the abundance of sialic acids in a2,3 linkage on
RBC inhibited the binding ability of 51/92 to sialic acids in
a2,6 linkage, we compared the ability of 51/92 and CM/88
to agglutinate CRBC from which sialic acids in a2,3 linkage
had been removed by a2,3-sialidase from Salmonella typhi-
murium LT2. Viruses that agglutinated HRBC with an HA
titer of 64 to 128 were used in the following experiments. As
shown in Fig. 3, CM/88 agglutinated these CRBC with an
HA titer of 64 to 128 (Fig. 3c), which is similar to that with
native CRBC (Fig. 3a). In contrast, 51/92 failed to agglutinate
these cells (Figs. 3a and 3c). To determine the binding
characteristics of the viruses to sialic acid in a2,3 or a2,6
inkage, we prepared derivatized CRBC resialylated with
Aa2,6Galb1,4GlcNAc and SAa2,3Galb1,3/4GlcNAc by sia-
lyltransferase, as described under Materials and Methods.
51/92 and CM/88 did not agglutinate VCNA-treated asialo
CRBC (Fig. 3b) or those resialylated with SAa2,3Galb1,3/
GlcNAc (Fig. 3d), but did agglutinate those resialylated
ith SAa2,6Galb1,4GlcNAc (Fig. 3e), although the amount
f incorporated sialic acids (average is 46 nmol/ml; Table 3)
as lower than that present on native CRBC (Table 2).
urthermore, both viruses agglutinated the derivatized
TABLE 2
Amount of Sialic Acid Released from Red Blood Cells (RBC)
by Sialidase
Sialidaseb from
Sialic acid (nmol/ml packed cells)a
Human RBC Chicken RBC
Vibrio cholerae 649,c 576 328, 295
rthrobacter 659, 584 382, 297
617d 325d
Salmonella typhimurium LT2 287, 265 243, 200
Newcastle disease virus 104, 52 161, 127
177e 182e
a Sialic acids were released by the respective sialidase and mea-
ured by HPLC as described in the text.
b Specificity of each sialidase is described in the text.
c Results were given of the two separate experiments except aver-
age values.
d Average total sialic acid content.
e Average amount of sialic acid in a2,3 linkage.RBC which had been treated with a2,3-sialidase and then
resialylated with a2,6-sialyltransferase (Fig. 3g). On the
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591A RECEPTOR DETERMINANT FOR RECENT HUMAN H3N2 VIRUSESother hand, 51/92 did not agglutinate CRBC which had been
treated with a2,3-sialidase and then resialylated with a2,3-
sialyltransferase, although CM/88 did (Fig. 3f). CM/88 might
bind to the authentic sialic acid remaining on CRBC after
a2,3-sialidase treatment rather than to the incorporated
SAa2,3Galb1,3/4GlcNAc sequence. If the sialic acids were
eleased from these resialylated CRBC by bacterial siali-
ase, either of the viruses no longer agglutinated these
BC.
Taking these results together, 51/92 exhibited prefer-
ntial binding to the SAa2,6Galb1,4GlcNAc sequence
ut not to SAa2,3Galb1,3/4GlcNAc or to the authentic
ialic acids on native CRBC. CM/88 exhibited a prefer-
nce for binding to sialic acid in the a2,6 linkage of
derivatized and native CRBC but not to the
SAa2,3Galb1,3/4GlcNAc sequence. The amount of sialic
cids incorporated into the derivatized CRBC ranged
rom 8 to 30% that of native CRBC (Table 3), which is
FIG. 3. Hemagglutination ability of 51/92 and CM/88 toward native
a2,3-sialidase (c, f, g) and then resialylated with the SAa2,3Galb1,3/4
xperiments were performed in triplicate. HA titers in each experiment
, sialic acid in a2,3 linkage on native CRBC; F, SAa2,6Galb1,4 GlcN
erivatized CRBC.imilar in range to that observed in previous studies
Carroll et al., 1981; Paulson and Rogers, 1987).
t
fhylogenetic study
On the basis of the amino acid sequences deduced from
ucleotide sequences of HA1 genes, phylogenetic relation-
hips among the human H3N2 influenza viruses isolated
fter 1988 were investigated. The phylogenetic analysis
howed that an amino acid change from Glu to Asp at
osition 190 of H3 HA had occurred after 1991 and that Asp
90 was retained in the trunk lineage until 1999. There was
recent report of H3N2 human influenza viruses isolated in
996/1997 bearing Glu 190 or Val 190 in the HA (Bush et al.,
999). Neither of these changes was observed in our Ch2
iruses. We do not know whether these viruses aggluti-
ated CRBC. In our previous study, however, we indicated
hat Asp 190 was retained in the trunk lineage of other
ecent H3N2 Ch2 human influenza viruses isolated from
996 to 1999 (Sato et al., 2000). We also confirmed the
dentity of nucleotide sequences of HA gene cDNA ob-
derivatized CRBC (b–g). CRBC were treated with VCNA (b, d, e) or
c sequence (d, f), or with the SAa2,6Galb1,4GlcNAc sequence (e, g).
own separately (1, 2, 3). E, Sialic acid in a2,6 linkage on native CRBC;
uence on derivatized CRBC; , SAa2,3Galb1,3/4GlcNAc sequence on(a) and
GlcNA
are shained from PCR products of clinical samples and those
rom plaque-purified viruses.
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592 NOBUSAWA ET AL.DISCUSSION
Receptor binding of viruses is sometimes restricted by
he number of receptor determinants on the target cells.
-Acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2) is a re-
eptor determinant for attachment of influenza C virus,
oronavirus, and hemagglutinating encephalomyelitis vi-
us to RBC (Rogers et al., 1986; Vlasak et al., 1988;
Schultze et al., 1990). HRBC and 1-day-old chicken eryth-
rocytes bear few Neu5,9Ac2 moieties, and the three
bove-mentioned viruses usually cannot agglutinate
hese erythrocytes. However, if the erythrocytes were
esialylated with Neu5,9Ac2, they were agglutinated by
these viruses, although the efficiency differed, depend-
ing on the amount of Neu5,9Ac2 incorporated (Schultze
et al., 1990). In this case, the number of receptor deter-
minants on the erythrocytes was a limiting factor for the
agglutination capacity of the viruses. On the other hand,
sialic acids in a2,6 linkage were detected on native
CRBC and their amount on these cells was sufficient for
agglutination by H3N2 human influenza viruses, such as
A/Aichi/2/68, A/Udorn/302/72, and A/Victoria/3/75, which
preferentially bind to sialic acids in this type of linkage
(Connor et al., 1994; Ito et al., 1997a). However, Ch2 virus
id not agglutinate native CRBC, even though they did
gglutinate derivatized CRBC, which contained a lower
mount of sialic acid in the a2,6 linkage compared to that
n native CRBC.
Martin et al. (1998) reported that Y98F, a receptor-site
utant with weak receptor-binding ability, could not ag-
lutinate suspensions of 0.7% turkey and human eryth-
ocytes. However, Y98F could agglutinate dilute prepa-
TABLE 3
Sialic Acid Incorporated into Derivatized Chicken Red
Blood Cells (CRBC)
CRBC preparation
Sialic acid incorporated
(nmol/ml)a
Experimentb
1 2 3
VCNAc3 a2,6 STd 47 47 44
VCNA3 a2,3 STe 98 56 68
a2,3-Sialidase f3 a2,6 ST 35 25 42
a2,3-Sialidase3 a2,3 ST 83 76 82
a The amount of incorporated sialic acid is deduced by subtracting
he amount of sialic acid on respective sialidase treated-RBCs from
hat on derivatized RBC resialylated by the respective sialytransferase.
b Number of experiment corresponds to that in Fig. 3.
c Vibrio cholerae sialidase.
d Galb1,4GlcNAc a2,6 sialyltransferase.
e Galb1,3/4GlcNAc a2,3 sialyltransferase.
f a2,3 sialidase from Salmonella typhimurium LT2.ations of 0.3 and 0.5% RBC. As for Ch2 viruses, they
ere unable to agglutinate CRBC, even in 0.1, 0.3, and.5% suspensions, although they could agglutinate
RBC in suspensions as high as 1%. Therefore the
eceptor-binding ability of Ch2 viruses may not neces-
arily be weak, although the range of binding specificity
ight become increasingly narrow compared to that of
revious viruses (Connor et al., 1994).
Eisen et al. (1997) described the structures of hemag-
lutinin (H3)–sialyloligosaccharide complexes, as deter-
ined by X-ray crystallography. These investigators in-
icated that the difference between the structures of a
entasaccharide with a2,6 linkage and a trisaccharide
,6-sialyllactose complexes with HA. Their results sug-
ested that the binding affinity of these receptor analogs
o HA might be different, although both analogs had the
ame a2,6 linkage at terminal sialic acid. It was possible
hat the sialyloligosaccharides attached to the glycocon-
ugates have different conformations and exhibit different
ffinities to HAs from sialyloligosaccharides unbound to
lycoconjugates.
In this study, to elucidate the preferred structure of the
atural receptor molecule reactive with 51/92, we utilized
erivatized RBC instead of free sialyloligosaccharides. The
erivatized CRBC was prepared using sialyltransferases
hat generate the sequences SAa2,6Galb1,4GlcNAc and
Aa2,3Galb1,3/4GlcNAc, which are commonly found as
erminal sequences in N-linked oligosaccharides (Wein-
tein et al., 1982). As demonstrated in Fig. 3, both viruses,
51/92 (Ch2) and CM/88 (Ch1), agglutinated derivatized
CRBC bearing SAa2,6Galb1,4GlcNAc but not those bearing
SAa2,3Galb1,3/4GlcNAc, which showed preference in
inding similar to that of previous H3N2 human influenza
iruses (Connor et al., 1994). However, these previous vi-
uses including A/Aichi/2/68 could agglutinate native CRBC
Ito et al., 1997a). On the other hand, Kurosawa et al. (1994)
isolated cDNA encoding Galb1,4GlcNAc a2,6-sialyltrans-
erase from chicken embryonic cDNA libraries. Therefore
he SAa2,6Galb1,4GlcNAc sequence could be characteris-
tic of sialyloligosaccharides of native CRBC. Nevertheless,
51/92 did not agglutinate native CRBC, whereas CM/88 did.
One possible explanation for this result is that the receptor
determinant reactive with 51/92 might be not only the ter-
minal sialic acid in a2,6Gal linkage but also the asialo
portion of sialyloligosaccharides on CRBC.
Glu 190 of HA of the X-31 strain is located in a short
a-helix forming the receptor-binding site (Wilson et al.,
1981) and is conserved in the majority of HAs of all
subtypes sequenced (Kawaoka et al., 1990; Nobusawa et
al., 1991; Rho¨m et al., 1995). Although residue 190 of X-31
HA is hydrogen bonded to the 9-OH of sialic acid (Weis
et al., 1988), Martin et al. (1998) suggested that the Glu
190/9-OH interaction does not appear to be essential for
the binding of the HA to HRBC because one of their
receptor mutant HAs, E190A, had a greater capacity to
bind to HRBC than did wild type HA; however, they did
not examine the binding of the mutant to CRBC. In our
study, Asp 190 also failed to abrogate the HRBC binding
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593A RECEPTOR DETERMINANT FOR RECENT HUMAN H3N2 VIRUSESability of 51-HA, but did render it unable to bind to CRBC.
It is possible that Glu 190/9-OH interaction might be
essential for the binding of the HA to CRBC.
Previously, an investigation of the asialo portion of
receptor microdomains, using natural and synthetic sia-
losides, indicated that there was no specific recognition
of certain asialo portions of the sialosides and that the
magnitude of the contribution of the asialo portion varied,
depending on the virus type, subtype, and strain (Pritch-
ett et al., 1987; Matrosovich et al., 1993; Gambaryan et al.,
995). On the basis of our findings, we could propose a
ypothesis that an amino acid change in E190D of HA
ossibly affected the distinction between asialo portions
f sialyloligosaccharides on derivatized and on native
RBC but not between terminal sialic acid linkages.
lthough we found that the SAa2,6Galb1,4GlcNAc se-
quence on certain sialyloligosaccharides of derivatized
CRBC was necessary for receptor binding by 51/92, a
contribution of more distant parts of the receptor mole-
cule remains to be defined.
Cultivation of influenza viruses in different host cells is
known to lead to a number of receptor-binding variants.
Gambaryan et al. as well as others previously indicated
that adaptation to the host cell environment was closely
related to the degree to which the virus could bind to the
cell, and this in turn was affected by host-dependent
glycosylation of HA or by amino acid changes adjacent
to the HA receptor-binding site (Gambaryan et al., 1997,
1998, 1999; Govorkova et al., 1999). Ito et al. (1997b)
eported differences in the amount of SAa2,3Gal and
SAa2,6Gal in different host cells and demonstrated that
he absence of the SAa2,6Gal moiety in egg allantois of
hicken eggs could be correlated with the appearance of
ost cell variants with altered receptor specificity. They
lso showed that MDCK cells contain both SAa2,3Gal
and SAa2,6Gal, and therefore human influenza viruses
assaged in MDCK cells retained their authentic recep-
or-binding character without any amino acid substitu-
ions in HA. Since the Ch2 viruses investigated in this
tudy were isolated directly in MDCK cells, their recep-
or-binding ability should be authentic and not the result
f selection for preferential-binding variants. Ch2 vi-
uses hardly grow in embryonated chicken eggs and an
gg-adapted virus could not be obtained by three pas-
ages in eggs. However, we previously obtained an
gg-adapted form from an H1N1 virus, which did not
gglutinate CRBC, by passaging this virus three times in
ggs (Morishita et al., 1996). The egg-adapted virus
ained the ability to agglutinate CRBC and acquired an
mino acid change in its HA. When one considers that
accine strains are usually grown in eggs, it is possible
hat these viruses were egg-adapted and had developed
receptor-binding specificity that was different from
heir intrinsic specificity.In the current study, using derivatized RBC and HPLC,
e examined the altered receptor-binding ability of re-ent human influenza viruses which do not agglutinate
RBC. The biological significance of this change in bind-
ng ability remains to be elucidated. To investigate this
iological significance, we are continuing to examine
mino acid substitutions in the receptor-binding site of
irculating human influenza virus HA and their effect on
eceptor recognition and pathogenicity in infected indi-
iduals.
MATERIALS AND METHODS
iruses
The H3N2 human influenza viruses, 51/92, 48/93, 18/
5, 46/96, 30/97, 11/98, and 3/99, were derived from
linical samples (throat swabs). All viruses used in this
tudy were grown in MDCK cells. The virus-infected cells
ere maintained in Dulbecco’s minimum essential me-
ium (DMEM) supplemented with 0.3% bovine albumin
olution and acetyltrypsin (2.5 mg/ml). Viruses were pu-
ified by plaque purification in MDCK cells in the pres-
nce of 2.5 mg/ml acetyltrypsin. MDCK cells and Cos
cells were grown in DMEM supplemented with 7% fetal
calf serum.
HA cDNA cloning
The cDNA of the HA gene was prepared by reverse
transcription of virus RNA using Moloney murine leuke-
mia virus reverse transcriptase (GIBCO BRL, Life Tech-
nologies, Gaithersburg, MD) and HA-specific primers
H3HA-1 (59-CCGGGAATTCAGCAAAAGCAGGGG-39) with
an EcoRI site built in (underlined) for HA1, and H3HA-645
(59-GAACAAACCAACCTATAT-39) for HA2. The cDNA was
amplified with additional antisense primers H3HAR-1140
(59-GCCTGAAACCGTACCAACC-39) for HA1 and H3HAR-
1765 (59-CCGGTCTAGAAGTAGAAACAAGGGT-39) with
XbaI site built in (underlined) for HA2, and amplification
was carried out by means of a polymerase chain reaction
(PCR) using Takara LA Taq polymerase (Takara Biomedi-
cals, Japan). The PCR fragments of HA1 and HA2 were
digested with EcoRI and PstI and PstI and XbaI, respec-
tively. Then both fragments were cloned into the EcoRI
and XbaI sites of a mammalian expression vector,
pME18S, containing the origin of SV40 and the SRa
promoter, which is composed of the SV40 early promoter
and R and part of the U5 sequence of the long terminal
repeat of human T-cell leukemia virus type 1 (Takebe et
al., 1988; Morishita et al., 1996). The resulting plasmids
carrying HA cDNA (pMEHAs) were used for experiments
of the expressed HA.
HA expression and hemadsorption
Cos cells grown on glass coverslips (18-mm diameter)
were transfected with 250 ng of expression plasmid
carrying HA cDNA (pMEHA) using Lipofectamine re-
agent (GIBCO BRL) according to the manufacturer’s pro-
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cells were washed with DMEM and hemadsorption tests
were performed with a freshly prepared suspension of
CRBC and HRBC at 4°C for 0.5 h. Unadsorbed erythro-
cytes were washed out with DMEM and hemadsorption-
positive cells were observed under a phase-contrast
microscope. For quantification, the Cos cells and eryth-
rocytes were lysed with distilled water. Cell debris was
removed by centrifugation, and the released hemoglobin
was measured by absorbance at 540 nm as described
previously (Ohuchi et al., 1995). Sialidase treatment was
performed by incubation of the Cos cells with 1 unit/ml of
VCNA solution (Boehringer Mannheim, Gmbh, Mann-
heim, Germany) at 37°C for 1 h as described previously
(Ohuchi et al., 1995).
Cell-surface fluorescence analysis
For detection of the cell-surface expression of HA, 4 3
105 Cos cells expressing HA were detached from cover
glasses with EDTA and trypsin, washed with PBS con-
taining 1% BSA, and fixed with 1% paraformaldehyde at
room temperature for 20 min with gentle agitation. The
fixed cells were stained with anti A/Udorn/72 hyperim-
mune rabbit serum, which could recognize both 51-HA
and CM-HA, and fluorescein-conjugated goat anti-rabbit
immunoglobulin G antibody. After suspension in 1 ml of
PBS, cells were subjected to fluorescence-activated cell
sorting (Becton–Dickinson, Rutherford, NJ) analysis.
Construction of chimeric HA and mutant HA
The cDNA of 51-HA was partially replaced with the
corresponding region of CM-HA at the respective restric-
tion enzyme recognition sites to construct three HA chi-
meras between 51-HA and CM-HA (Fig. 2). cDNAs of
51-HA and CM-HA were digested with XbaI and BsiHKAI,
and the fragments were cloned into the EcoRI and XbaI
sites of pME18S.
Site-specific mutations in HA (51-mut1 to mut5 and
CM-mut1 to mut5) were generated by PCR with mutant
primers by site-specific mutagenesis using a Takara LA
PCR in vitro mutagenesis kit (Takara Biomedicals) ac-
cording to the manufacturer’s protocol. Mutagenic prim-
ers used for 51-mut1 to mut5 were 59-CGAGCATCAGG-
GAGAGTCACAG-39, 59-CGGACCGTGAGCAAACCAAC-
CTATATGTTCGAG-39, 59-CGGACCGTGAGCAAACCA-
GCCTATATGTTCG-39, 59-AGTGAGCAAACCAGCCTATAT-
GTTCG-39, and 59-GGACCGTGACCAAACCAGCCT-
ATATG-39, respectively; and those used for CM-mut1 to
mut5 were 59-GTTCGAGAATCAGGGAGAGTCACAG-39,
59-CAGACAGTGACCAAACCAGCCTATATGTTCGA-39, 59-
CAGACAGTGACCAAACCAACCTATATGTTC-39, 59-CAGA-
CAGAGACCAAACCAACCTATATG-39, and 59-CAGACAGT-
GAACAAACCAACCTATATG-39, respectively. After the se-
quences were confirmed, the fragments were inserted
into corresponding regions of the pMEHAs.
w
uMeasurement of sialic acid content
CRBC and HRBC were incubated for 1 h at 37°C in a
100-ml suspension (10% v/v) in PBS containing 50 mU of
he respective sialidase as described previously (Paul-
on and Rogers, 1987; Schultze et al., 1990). Sialidases
rom Vibrio cholerae and Arthrobacter (Boehringer Mann-
heim) hydrolyze terminal N- or O-linked sialic acids in
a2,3, a2,6, or a2,8 linkage with glycoconjugates, which
ensures their complete removal from these glycoconju-
gates. a2,3-Sialidase from Salmonella typhimurium LT2
(Takara Biomedicals) and Newcastle disease virus (NDV)
(Boehringer Mannheim) specifically cleaves a terminal
sialic acid in a2,3 linkage with N- or O-glycosidically
ound oligosaccharide chains of glycoproteins and gly-
olipids, but does not cleave sialic acids in a2,6 linkage.
As a control, RBC suspension was also incubated with-
out sialidase. After the incubation, the RBC suspension
was centrifuged and the supernatant was used for quan-
titative determination of the sialic acid content of these
cells using HPLC with fluorescence detection (Hara et
al., 1989). Briefly, the sialic acids in the supernatant were
derivatized with 1,2-diamino-4,5-methylenedioxybenzene
(DMB) and the derivatives were then separated on a
reverse-phase Palpak Type R column (0.46 3 25 cm;
Takara Biomedicals) column. The mobile phase was a
mixture of acetonitrile–methanol–water (9:7:84, v/v) and
the flow rate was 0.9 ml/min. The column temperature
was maintained at 30°C. The DMB derivatives of sialic
acids were detected with a fluorescence detector (Model
RF-10A; Shimadzu Corp., Japan), which was operated at
an emission wavelength of 448 nm and an excitation
wavelength of 373 nm. DMB-NeuAc and DMB-NeuGc
were used as standards. Linear relationships were ob-
served between the peak height and the amount of each
neuraminic acid up to a concentration of 10 pmol/50 ml.
Preparation of resialylated erythrocytes
CRBC were sialylated essentially as previously de-
scribed (Paulson and Rogers, 1987; Shultze et al., 1990)
using Galb1,4GlcNAc a2,6-sialyltransferase or Galb1,3/
4GlcNAc a2,3-sialyltransferase (Carroll et al., 1981). Sus-
pensions (10%) of CRBC or HRBC were prepared in PBS
and 100-ml aliquots of these suspensions were incu-
bated with 50 mU of VCNA and a2,3-sialidase from S.
yphimurium LT2. After 1 h at 37°C, the erythrocytes were
ashed twice with PBS and resuspended in 50 ml PBS
ontaining 1% bovine serum albumin. After addition of 2.5
U of Galb1,4GlcNAc a2,6-sialyltransferase (Boehringer
annheim) or Galb1,3/4GlcNAc a2,3-sialyltransferase
Calbiochem Biosciences, La Jolla, CA) and CMP–N-
cetylneuraminic acid (Sigma Chemical, St. Louis, MO)
o give a final concentration of 1.5 mM, the erythrocytes
ere incubated at 37°C for 4 h. The erythrocytes were
ashed three times, resuspended in 2 ml of PBS, and
sed for HA titration. For quantitative determination of
CE
595A RECEPTOR DETERMINANT FOR RECENT HUMAN H3N2 VIRUSESsialic acids in the derivatized erythrocytes, sialic acids
were released with VCNA, labeled with 1,2-diamino-4,5-
methylenedioxybenzene, and then subjected to HPLC
analysis as described above.
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